|
US 11,814,357 B2 |
|
| Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof |
| Han-Jie Zhou, Foster City, CA (US); and Peter Virsik, Portola Valley, CA (US) |
| Assigned to ESSA Pharma Inc., Vancouver (CA) |
| Filed by ESSA Pharma Inc., Vancouver (CA) |
| Filed on Dec. 5, 2022, as Appl. No. 18/061,743. |
| Application 18/061,743 is a continuation of application No. 17/732,081, filed on Apr. 28, 2022, granted, now 11,518,747, issued on Dec. 6, 2022. |
| Application 17/732,081 is a continuation of application No. 17/526,660, filed on Nov. 15, 2021, granted, now 11,358,938, issued on Jun. 14, 2022. |
| Application 17/526,660 is a continuation of application No. 17/342,923, filed on Jun. 9, 2021, granted, now 11,242,324, issued on Feb. 8, 2022. |
| Application 17/342,923 is a continuation of application No. 17/233,161, filed on Apr. 16, 2021, abandoned. |
| Claims priority of provisional application 63/011,671, filed on Apr. 17, 2020. |
| Prior Publication US 2023/0104598 A1, Apr. 6, 2023 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. A61K 31/505 (2006.01); A61K 31/4164 (2006.01); C07D 239/69 (2006.01); A61K 45/06 (2006.01); C07D 239/42 (2006.01) |
